106 related articles for article (PubMed ID: 2483984)
1. [Clinical significance of fibronectin and protease inhibitors in chronic obstructive pulmonary diseases].
Dong BR
Zhonghua Jie He He Hu Xi Za Zhi; 1989 Dec; 12(6):343-6, 381. PubMed ID: 2483984
[TBL] [Abstract][Full Text] [Related]
2. [The changes in collagen contents and its clinical significance in chronic obstructive pulmonary disease].
Dong B; Zhou J; Wang Z
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):301-2, 319. PubMed ID: 8762485
[TBL] [Abstract][Full Text] [Related]
3. [Molecular degradation forms of plasma fibronectin in patients with chronic obstructive pulmonary disease].
Ding YH; Lu YQ; Cheng JG
Zhonghua Jie He He Hu Xi Za Zhi; 1994 Oct; 17(5):305-7, 320. PubMed ID: 7712576
[TBL] [Abstract][Full Text] [Related]
4. Natural protease inhibitors to fibrinolysis in liver diseases.
Arnman R; Gyzander E; Hedner U; Olsson R; Teger-Nilsson AC
Hepatogastroenterology; 1980 Aug; 27(4):254-8. PubMed ID: 6162766
[TBL] [Abstract][Full Text] [Related]
5. [Changes of plasma fibronectin and antithrombin III in pregnancy-induced hypertension].
Tong Y
Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):6-8, 60. PubMed ID: 2004575
[TBL] [Abstract][Full Text] [Related]
6. [Antiproteolytic potential of the blood serum in chronic nonspecific lung diseases].
Kaminskaia GO; Zhukova NL; Ozerova LB
Sov Med; 1986; (10):77-81. PubMed ID: 2433771
[No Abstract] [Full Text] [Related]
7. [Pulmonary veno-arterial alpha 1 protease inhibitor differences in patients with chronic lung disease].
Ishizaki T; Azuma H; Takahashi H; Amejima S; Kishi Y; Sasaki F; Miyabo S
Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Jan; 26(1):3-9. PubMed ID: 3259645
[No Abstract] [Full Text] [Related]
8. [Pi phenotypes of alpha-1-antitrypsin and antiproteases in meningococcal sepsis].
Ruiz C; Blanco Quirós A; Solís P; Alvarez Guisasola J; Sánchez Villares E
An Esp Pediatr; 1983 Oct; 19(4):268-78. PubMed ID: 6197915
[TBL] [Abstract][Full Text] [Related]
9. Screening of concentrations of C-reactive protein and various plasma protease inhibitors preoperatively for the prediction of postoperative complications.
Göransson J; Jonsson S; Lasson A
Eur J Surg; 1998 Feb; 164(2):89-101. PubMed ID: 9537715
[TBL] [Abstract][Full Text] [Related]
10. Ten-year changes of protease inhibitors in the sons of patients with COPD.
Yoshioka A; Nagata H; Yamamoto M; Akiyama Y; Nishimura M; Miyamoto K; Kishi F; Kawakami Y
Ann N Y Acad Sci; 1991; 624():359-61. PubMed ID: 1712158
[No Abstract] [Full Text] [Related]
11. Sepsis and antithrombin III, prekallikrein, and fibronectin levels in surgical patients.
Wilson RF; Farag A; Mammen EF; Fujii Y
Am Surg; 1989 Jul; 55(7):450-6. PubMed ID: 2742228
[TBL] [Abstract][Full Text] [Related]
12. [Plasma proteinase inhibitors and their clinical significance].
Prandota J; Kotecki L
Pediatr Pol; 1995 Aug; 70(8):667-72. PubMed ID: 8668369
[No Abstract] [Full Text] [Related]
13. [Inhibitors of serum proteinases].
Jendryczko A; Drózdz M
Wiad Lek; 1985 Dec; 38(23):1654-9. PubMed ID: 2421489
[No Abstract] [Full Text] [Related]
14. Influence of plasma protease inhibitors and the secretory leucocyte protease inhibitor on leucocyte elastase-induced consumption of selected plasma proteins in vitro in man.
Björk P; Axelsson L; Bergenfeldt M; Ohlsson K
Scand J Clin Lab Invest; 1988 Apr; 48(2):205-11. PubMed ID: 2451859
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
[TBL] [Abstract][Full Text] [Related]
16. Proteases and antiproteases related to the coagulation system in plasma and ascites--an approach to differentiate between malignant and cirrhotic ascites.
Schölmerich J; Zimmermann U; Köttgen E; Volk BA; Ehlers S; Gerok W
Klin Wochenschr; 1987 Jul; 65(14):634-8. PubMed ID: 2442449
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of determining endogenous proteinase inhibitors in cancer patients].
Shcherbak IG; Potashov LV; Levin AO; Kulikova AI; Sitkevich RV
Vopr Onkol; 1987; 33(3):22-6. PubMed ID: 2436380
[TBL] [Abstract][Full Text] [Related]
18. Concentration of fibronectin and granulocyte elastase in plasma of patients with systemic connective-tissue diseases.
Schneider M; Lohmann J; Krummenerl T; Gerlach U
Int J Tissue React; 1987; 9(4):355-9. PubMed ID: 3497902
[TBL] [Abstract][Full Text] [Related]
19. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P
Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
[TBL] [Abstract][Full Text] [Related]
20. The behavior of antithrombin III, alpha 2 macroglobulin, and alpha 1 antitrypsin during cardiopulmonary bypass.
Pickering NJ; Brody JI; Fink GB; Finnegan JO; Ablaza S
Am J Clin Pathol; 1983 Oct; 80(4):459-64. PubMed ID: 6194683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
